{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:39:36Z","timestamp":1757619576949,"version":"3.44.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02847-2","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T02:16:35Z","timestamp":1753409795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tacrolimus eye drops treatment for recurrent exposure of the Ahmed glaucoma valve tube"],"prefix":"10.1186","volume":"30","author":[{"given":"Li-Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"issue":"6","key":"2847_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ajo.2007.07.035","volume":"144","author":"C Souza","year":"2007","unstructured":"Souza C, Tran DH, Loman J, et al. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol. 2007;144(6):893\u2013900.","journal-title":"Am J Ophthalmol"},{"key":"2847_CR2","first-page":"547","volume":"10","author":"M Chaku","year":"2016","unstructured":"Chaku M, Netland PA, Ishida K, et al. Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery. Clin Ophthalmol. 2016;10:547\u201353.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"2847_CR3","first-page":"469","volume":"6","author":"S Thakur","year":"2017","unstructured":"Thakur S, Ichhpujani P, Kumar S. Grafts in glaucoma surgery: a review of the literature. Asia Pac J Ophthalmol. 2017;6(5):469\u201376.","journal-title":"Asia Pac J Ophthalmol"},{"issue":"7","key":"2847_CR4","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0161-6420(01)00598-X","volume":"108","author":"SJ Gedde","year":"2001","unstructured":"Gedde SJ, Scott IU, Tabandeh H, et al. Late endophthalmitis associated with glaucoma drainage implants. Ophthalmology. 2001;108(7):1323\u20137.","journal-title":"Ophthalmology"},{"issue":"4","key":"2847_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/IJG.0000000000001186","volume":"28","author":"X Liu","year":"2019","unstructured":"Liu X, Law SK. Autologous partial-thickness scleral flap and donor corneal graft in management of tube erosion of glaucoma drainage device. J Glaucoma. 2019;28(4):347\u201351.","journal-title":"J Glaucoma"},{"issue":"3","key":"2847_CR6","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1097\/IJG.0000000000000427","volume":"26","author":"S Dubey","year":"2017","unstructured":"Dubey S, Rajurkar K, Kapur N, et al. Heterologous, human donor sclera as the patch graft in glaucoma drainage device surgery. J Glaucoma. 2017;26(3):e128\u20139.","journal-title":"J Glaucoma"},{"issue":"9","key":"2847_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014500","volume":"98","author":"Y Wang","year":"2019","unstructured":"Wang Y, Li X, Huang W, et al. Partial thickness cornea tissue from small incision lenticule extraction: a novel patch graft in glaucoma drainage implant surgery. Medicine. 2019;98(9): e14500.","journal-title":"Medicine"},{"issue":"7","key":"2847_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/aos.13721","volume":"96","author":"WM van Hoefen","year":"2018","unstructured":"van Hoefen WM, Haan M, Rietveld E, et al. Donor sclera versus bovine pericardium as patch graft material in glaucoma implant surgery and the impact of a drainage suture. Acta Ophthalmol. 2018;96(7):692\u20138.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"2847_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12886-018-0721-6","volume":"18","author":"A Rosentreter","year":"2018","unstructured":"Rosentreter A, Lappas A, Widder RA, et al. Conjunctival repair after glaucoma drainage device exposure using collagen-glycosaminoglycane matrices. BMC Ophthalmol. 2018;18(1):60.","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"2847_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/IJG.0000000000000951","volume":"27","author":"A Einan-Lifshitz","year":"2018","unstructured":"Einan-Lifshitz A, Belkin A, Mathew D, et al. Repair of exposed ahmed glaucoma valve tubes: long-term outcomes. J Glaucoma. 2018;27(6):532\u20136.","journal-title":"J Glaucoma"},{"issue":"3","key":"2847_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/112067211002000302","volume":"20","author":"L Zeppa","year":"2010","unstructured":"Zeppa L, Romano MR, Capasso L, et al. Sutureless human sclera donor patch graft for ahmed glaucoma valve. Eur J Ophthalmol. 2010;20(3):546\u201351.","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"2847_CR12","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","volume":"40","author":"T Kino","year":"1987","unstructured":"Kino T, Hatanaka H, Miyata S, et al. Fk-506, a novel immunosuppressant isolated from a Streptomyces. Ii. Immunosuppressive effect of fk-506 in vitro. J Antibiot. 1987;40(9):1256\u201365.","journal-title":"J Antibiot"},{"issue":"9 Suppl","key":"2847_CR13","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1097\/01.TP.0000126926.61434.A5","volume":"77","author":"JJ Fung","year":"2004","unstructured":"Fung JJ. Tacrolimus and transplantation: a decade in review. Transplantation. 2004;77(9 Suppl):S41-43.","journal-title":"Transplantation"},{"issue":"1","key":"2847_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s40135-017-0119-2","volume":"5","author":"S Jabbehdari","year":"2017","unstructured":"Jabbehdari S, Rafii AB, Yazdanpanah G, et al. Update on the management of high-risk penetrating keratoplasty. Curr Ophthalmol Rep. 2017;5(1):38\u201348.","journal-title":"Curr Ophthalmol Rep"},{"issue":"6","key":"2847_CR15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.survophthal.2016.12.010","volume":"62","author":"A Di Zazzo","year":"2017","unstructured":"Di Zazzo A, Kheirkhah A, Abud TB, et al. Management of high-risk corneal transplantation. Surv Ophthalmol. 2017;62(6):816\u201327.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"2847_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41433-019-0517-9","volume":"34","author":"O Azevedo Magalhaes","year":"2020","unstructured":"Azevedo Magalhaes O, Shalaby Bardan A, Zarei-Ghanavati M, et al. Literature review and suggested protocol for prevention and treatment of corneal graft rejection. Eye. 2020;34(3):442\u201350.","journal-title":"Eye"},{"issue":"9","key":"2847_CR17","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41433-019-0717-3","volume":"34","author":"LY Zhai","year":"2020","unstructured":"Zhai LY, Zhang XR, Liu H, et al. Observation of topical tacrolimus on high-risk penetrating keratoplasty patients: a randomized clinical trial study. Eye. 2020;34(9):1600\u20137.","journal-title":"Eye"},{"issue":"5","key":"2847_CR18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ajo.2012.12.009","volume":"155","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Kim SW, Seo KY. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases. Am J Ophthalmol. 2013;155(5):804\u201313.","journal-title":"Am J Ophthalmol"},{"key":"2847_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajo.2015.11.023","volume":"163","author":"DL Budenz","year":"2016","unstructured":"Budenz DL, Feuer WJ, Barton K, et al. Postoperative complications in the ahmed baerveldt comparison study during five years of follow-up. Am J Ophthalmol. 2016;163:75-82.e73.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"2847_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/IJG.0000000000000034","volume":"24","author":"V Trubnik","year":"2015","unstructured":"Trubnik V, Zangalli C, Moster MR, et al. Evaluation of risk factors for glaucoma drainage device-related erosions: a retrospective case-control study. J Glaucoma. 2015;24(7):498\u2013502.","journal-title":"J Glaucoma"},{"issue":"2","key":"2847_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00061198-200204000-00010","volume":"11","author":"MF Smith","year":"2002","unstructured":"Smith MF, Doyle JW, Ticrney JW. A comparison of glaucoma drainage implant tube coverage. J Glaucoma. 2002;11(2):143\u20137.","journal-title":"J Glaucoma"},{"issue":"1","key":"2847_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/IJG.0b013e318133fc49","volume":"17","author":"D Lankaranian","year":"2008","unstructured":"Lankaranian D, Reis R, Henderer JD, et al. Comparison of single thickness and double thickness processed pericardium patch graft in glaucoma drainage device surgery: a single surgeon comparison of outcome. J Glaucoma. 2008;17(1):48\u201351.","journal-title":"J Glaucoma"},{"issue":"6","key":"2847_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/IJG.0b013e3181f3e5b4","volume":"22","author":"SM Huddleston","year":"2013","unstructured":"Huddleston SM, Feldman RM, Budenz DL, et al. Aqueous shunt exposure: a retrospective review of repair outcome. J Glaucoma. 2013;22(6):433\u20138.","journal-title":"J Glaucoma"},{"issue":"10","key":"2847_CR24","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.ophtha.2005.04.030","volume":"112","author":"CG Owen","year":"2005","unstructured":"Owen CG, Newsom RS, Rudnicka AR, et al. Vascular response of the bulbar conjunctiva to diabetes and elevated blood pressure. Ophthalmology. 2005;112(10):1801\u20138.","journal-title":"Ophthalmology"},{"issue":"4","key":"2847_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4103\/jovr.jovr_219_17","volume":"13","author":"D Zhou","year":"2018","unstructured":"Zhou D, Zhou XY, Mas-Ramirez AM, et al. Factors associated with conjunctival erosions after ahmed glaucoma valve implantation. J Ophthalmic Vis Res. 2018;13(4):411\u20138.","journal-title":"J Ophthalmic Vis Res"},{"issue":"3","key":"2847_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.4103\/ijo.IJO_1846_22","volume":"71","author":"S Panda","year":"2023","unstructured":"Panda S, Khurana M, Vijaya L, et al. Comparison of conjunctiva-related complications between scleral and corneal patch grafts in ahmed glaucoma valve implantation. Indian J Ophthalmol. 2023;71(3):881\u20137.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"2847_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10384-008-0630-y","volume":"53","author":"YS Byun","year":"2009","unstructured":"Byun YS, Lee NY, Park CK. Risk factors of implant exposure outside the conjunctiva after ahmed glaucoma valve implantation. Jpn J Ophthalmol. 2009;53(2):114\u20139.","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"2847_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004560","volume":"4","author":"KW Muir","year":"2014","unstructured":"Muir KW, Lim A, Stinnett S, et al. Risk factors for exposure of glaucoma drainage devices: a retrospective observational study. BMJ Open. 2014;4(5): e004560.","journal-title":"BMJ Open"},{"issue":"6","key":"2847_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/IJG.0000000000001220","volume":"28","author":"AS Al-Beishri","year":"2019","unstructured":"Al-Beishri AS, Malik R, Freidi A, et al. Risk factors for glaucoma drainage device exposure in a middle-eastern population. J Glaucoma. 2019;28(6):529\u201334.","journal-title":"J Glaucoma"},{"issue":"4","key":"2847_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/bjo.2005.084905","volume":"90","author":"G Ainsworth","year":"2006","unstructured":"Ainsworth G, Rotchford A, Dua HS, et al. A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery. Br J Ophthalmol. 2006;90(4):417\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"2847_CR31","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/IJG.0000000000001060","volume":"27","author":"JM Guajardo","year":"2018","unstructured":"Guajardo JM, Lim KS. Long-term safety and efficacy of conjunctival pedicle graft revision combined with repeated pericardium allograft for exposed glaucoma drainage devices. J Glaucoma. 2018;27(10):910\u20133.","journal-title":"J Glaucoma"},{"issue":"12","key":"2847_CR32","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/IJG.0000000000000821","volume":"26","author":"AC Thompson","year":"2017","unstructured":"Thompson AC, Manjunath V, Muir KW. Risk factors for earlier reexposure of glaucoma drainage devices. J Glaucoma. 2017;26(12):1155\u201360.","journal-title":"J Glaucoma"},{"issue":"2","key":"2847_CR33","first-page":"102","volume":"49","author":"MW Zhou","year":"2013","unstructured":"Zhou MW, Wang W, Wang SM, et al. a comparison study of glaucoma drainage implant with three different of tube coverages. Zhonghua Yan Ke Za Zhi. 2013;49(2):102\u20138.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"1","key":"2847_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12886-018-0907-y","volume":"18","author":"OM Gedar Totuk","year":"2018","unstructured":"Gedar Totuk OM, Kabadayi K, Colakoglu A, et al. A novel surgical technique for prevention of ahmed glaucoma valve tube exposure: long scleral flap augmented with tenon advancement and duplication. BMC Ophthalmol. 2018;18(1):226.","journal-title":"BMC Ophthalmol"},{"issue":"42","key":"2847_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035745","volume":"102","author":"Y Dai","year":"2023","unstructured":"Dai Y, Gong JF, Zhu JM, et al. Long scleral tunnel technique for prevention of drainage tube-related complications during ahmed glaucoma valve implantation. Medicine. 2023;102(42): e35745.","journal-title":"Medicine"},{"issue":"1","key":"2847_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/PAJO.PAJO_45_20","volume":"2","author":"MA Vedovato","year":"2020","unstructured":"Vedovato MA, Thaynara Q, Mendes D, et al. Use of topical tacrolimus in ophthalmology: nonsystematic review. Pan-Am J Ophthalmol. 2020;2(1):36.","journal-title":"Pan-Am J Ophthalmol"},{"issue":"11","key":"2847_CR37","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/bjophthalmol-2013-303639","volume":"97","author":"OA Magalhaes","year":"2013","unstructured":"Magalhaes OA, Marinho DR, Kwitko S. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study. Br J Ophthalmol. 2013;97(11):1395\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"2847_CR38","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/ICO.0000000000002709","volume":"40","author":"K Yu","year":"2021","unstructured":"Yu K, Lian XF, Jiang XY, et al. Efficacy of immunosuppressants in high rejection risk keratoplasty: a meta-analysis of comparative studies. Cornea. 2021;40(6):800\u20137.","journal-title":"Cornea"},{"issue":"2","key":"2847_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1365-2567.2001.01288.x","volume":"104","author":"GP Geba","year":"2001","unstructured":"Geba GP, Ptak W, Askenase PW. Topical tacrolimus and cyclosporin a differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin e hypersensitivity. Immunology. 2001;104(2):235\u201342.","journal-title":"Immunology"},{"key":"2847_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejps.2018.04.038","volume":"120","author":"A Luaces-Rodr\u00edguez","year":"2018","unstructured":"Luaces-Rodr\u00edguez A, Touri\u00f1o-Peralba R, Alonso-Rodr\u00edguez I, et al. Preclinical characterization and clinical evaluation of tacrolimus eye drops. Eur J Pharm Sci. 2018;120:152\u201361.","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"2847_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/ICO.0000000000002751","volume":"40","author":"R Caputo","year":"2021","unstructured":"Caputo R, Marziali E, de Libero C, et al. Long-term safety and efficacy of tacrolimus 0.1% in severe pediatric vernal keratoconjunctivitis. Cornea. 2021;40(11):1395\u2013401.","journal-title":"Cornea"},{"issue":"5","key":"2847_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/ACI.0000000000000560","volume":"19","author":"N Erdinest","year":"2019","unstructured":"Erdinest N, Ben-Eli H, Solomon A. Topical tacrolimus for allergic eye diseases. Curr Opin Allergy Clin Immunol. 2019;19(5):535\u201343.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"2847_CR43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000478704","volume":"59","author":"Q Wan","year":"2018","unstructured":"Wan Q, Tang J, Han Y, et al. Therapeutic effect of 0.1% tacrolimus eye drops in the tarsal form of vernal keratoconjunctivitis. Ophthalmic Res. 2018;59(3):126\u201334.","journal-title":"Ophthalmic Res"},{"issue":"3","key":"2847_CR44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jaci.2021.03.026","volume":"148","author":"I Roumeau","year":"2021","unstructured":"Roumeau I, Coutu A, Navel V, et al. Efficacy of medical treatments for vernal keratoconjunctivitis: a systematic review and meta-analysis. J Allergy Clin Immunol. 2021;148(3):822\u201334.","journal-title":"J Allergy Clin Immunol"},{"key":"2847_CR45","first-page":"112067212199268","volume":"4","author":"P Moawad","year":"2021","unstructured":"Moawad P, Shamma R, Hassanein D, et al. Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to sjogren syndrome. Eur J Ophthalmol. 2021;4:1120672121992680.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"2847_CR46","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/1120672121992680","volume":"32","author":"P Moawad","year":"2022","unstructured":"Moawad P, Shamma R, Hassanein D, et al. Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to sjogren syndrome. Eur J Ophthalmol. 2022;32(1):673\u20139.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"2847_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12886-021-01998-0","volume":"21","author":"K Koh","year":"2021","unstructured":"Koh K, Jun I, Kim TI, et al. Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients. BMC Ophthalmol. 2021;21(1):247.","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"2847_CR48","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/bmt.2009.249","volume":"45","author":"PM Tam","year":"2010","unstructured":"Tam PM, Young AL, Cheng LL, et al. Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic gvhd. Bone Marrow Transplant. 2010;45(5):957\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2847_CR49","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/jop.2006.0105","volume":"23","author":"AD Van Eyk","year":"2007","unstructured":"Van Eyk AD, Van Der Bijl P, Meyer D. In vitro diffusion of the immunosuppressant tacrolimus through human and rabbit corneas. J Ocul Pharmacol Ther. 2007;23(2):146\u201351.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"2847_CR50","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S1567-5769(01)00059-5","volume":"1","author":"S Sakuma","year":"2001","unstructured":"Sakuma S, Higashi Y, Sato N, et al. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human pbmc system. (comparison with steroids). Int Immunopharmacol. 2001;1(6):1219\u201326.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2847_CR51","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1177\/11206721211023320","volume":"32","author":"RE Marques","year":"2022","unstructured":"Marques RE, Leal I, Guerra PS, et al. Topical corticosteroids with topical cyclosporine a versus topical corticosteroids alone for immunological corneal graft rejection. Eur J Ophthalmol. 2022;32(3):1469\u201381.","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"2847_CR52","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/ICO.0000000000001298","volume":"36","author":"R Ghaffari","year":"2017","unstructured":"Ghaffari R, Ghassemi H, Zarei-Ghanavati M, et al. Tacrolimus eye drops as adjunct therapy in severe corneal endothelial rejection refractory to corticosteroids. Cornea. 2017;36(10):1195\u20139.","journal-title":"Cornea"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02847-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:18:59Z","timestamp":1757287139000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02847-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2847"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02847-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"type":"electronic","value":"2047-783X"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent to publish the photographs included in this manuscript was obtained from the patient. A copy of a written consent of the patient is available for review by the Executive Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"669"}}